TDAC
NASDAQ
US
Translational Development Acquisition Corp. - Ordinary Shares
N/A
· N/A
· IPO Dec 2024
$10.56
▼ $-0.02
(-0.19%)
Vol 100
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$229.8M
P/E
48.3
ROE
2.8%
D/E
0.06
Beta
-0.24
52W
$10–$10
Price Chart
Earnings
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | 2.8% |
| P/E (TTM) | — | 160.11 | 74.59 | 75.38 | 75.31 | 48.29 |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Current Ratio | 0.55 | 1.29 | 0.55 | 0.55 | 0.55 | 0.19 |
Key Ratios
ROA (TTM)
2.7%
EPS (TTM)
$0.22
52W High
$10.48
52W Low
$10.00
$10.00
52-Week Range
$10.48
How does TDAC compare to N/A peers?
Peer group: Micro-cap N/A (All) · 453 companies
TDAC valuation vs N/A peers
P/E ratio
48.3
▼
15%
below
peers
(56.5)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(6.0)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(1.3)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(19.6%)
vs Peers
vs Industry
Low yield
TDAC profitability vs N/A peers
ROE
2.8%
▲
0%
above
peers
(2.8%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(0.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(63.5%)
vs Peers
vs Industry
Weak
ROA
2.7%
▲
2%
above
peers
(2.6%)
vs Peers
vs Industry
Weak
TDAC financial health vs N/A peers
D/E ratio
0.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
0.2
▼
83%
below
peers
(1.1)
vs Peers
vs Industry
Low liquidity
Beta
-0.2
▼
1298%
below
peers
(0.0)
vs Peers
vs Industry
More volatile
TDAC fundamentals radar
TDAC
Peer median
Industry
TDAC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TDAC vs peers: key metrics
Latest News
No related news yet